Report: AstraZeneca reviewing bids for Astra Tech

AstraZeneca is reviewing bids for its dental implant unit Astra Tech. "We have received a number of bids and we're looking at them and reviewing them. Once we have done that, we'll decide if and how we are going to sell it," AstraZeneca spokeswoman Ann-Leena Mikiver told Dow Jones, adding that the company may choose not to sell. Permira, Bain Capital, Nordic Capital, Cinven, Bridgepoint and Warburg Pincus are among the private equity firms that submitted bids by the first-round deadline on March 14, sources report. Swiss dental implant makers Straumann Holding AG and Nobel Biocare Holding AG, as well as big U.S. names like Medtronic, 3M, Danaher and Dentsply International may also be interested. Report

Suggested Articles

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.

Philips looked back on 15 years of data from one of its telehealth-equipped intensive care units, where centralizing operations reduced mortality.

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.